ClinicalTrials.gov · NCT04375657 · Recruiting
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
Registry record
NCT04375657 on ClinicalTrials.gov. The registry's last update to this record was 7 May 2025.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor Intervene Immune, Inc. Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention TRIIM Treatment; Active Control Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Epigenetic Age | Thymus Regeneration | Safety and Tolerability Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Recruiting Checked Source clinicaltrials.gov Overall status as registered; registry last update 2025-05-07. Checked
Check history: NCT04375657 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: Intervene Immune, Inc.
- Phase: Phase 2
- Status: Recruiting
- Intervention: TRIIM Treatment; Active Control
- Primary outcome: Epigenetic Age | Thymus Regeneration | Safety and Tolerability
- Countries: United States
- Start: 23 November 2020
- Completion (estimated): December 2025
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.